Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount |
---|---|---|---|---|---|---|
MERCK SHARP & DOHME LLC | Merck | pharmaceuticals | air pollution violation | 2024 | NJ-ENV | $33,200 |
BRISTOL - MYERS SQUIBB MEDICAL IMAGING INC | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2009 | EPA | $19,538 |
PFIZER GLOBAL MANUFACTURING | Pfizer | pharmaceuticals | air pollution violation | 2008 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $975,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2009 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,328,154 |
Bristol Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2008 | EPA | $66,770 |
Schering-Plough Products, LLC | Merck | pharmaceuticals | air pollution violation | 2011 | EPA | $260,000 |
Pfizer Pharmaceuticals, LLC | Pfizer | pharmaceuticals | air pollution violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $728,000 |
MERCK & CO., INC. | Merck | pharmaceuticals | air pollution violation | 2011 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,500,000 |
KING PHARMACEUTICALS | Pfizer | pharmaceuticals | air pollution violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
ABBOTT LABS-N CHICAGO PLANT | AbbVie | pharmaceuticals | air pollution violation | 2004 | EPA | $162,595 |
Pharmacia & Upjohn Company | Pfizer | pharmaceuticals | air pollution violation | 2005 | EPA | $676,250 |
ABBOTT LABS - N. CHICAGO PLANT | AbbVie | pharmaceuticals | air pollution violation | 2006 | EPA | $475,672 |
ELI LILLY AND COMPANY | Eli Lilly | pharmaceuticals | air pollution violation | 2011 | EPA | $337,500 |
ELI LILLY & COMPANY - TIPPECANOE LABS | Eli Lilly | pharmaceuticals | air pollution violation | 2009 | EPA | $12,000 |
ABBOTT LABS - N. CHICAGO PLANT | AbbVie | pharmaceuticals | air pollution violation | 2011 | EPA | $135,756 |
CSL Behring LLC | CSL Limited | pharmaceuticals | air pollution violation | 2015 | EPA | $62,780 |
KREMERS URBAN PHARMACEUTICALS INC | Lannett Co. | pharmaceuticals | air pollution violation | 2018 | EPA | $285,000 |
CSL BEHRING LLC | CSL Limited | pharmaceuticals | air pollution violation | 2021 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $527,144 |
MALLINCKRODT, INC | Mallinckrodt | pharmaceuticals | air pollution violation | 2004 | EPA | $80,160 |
SIGMA ALDRICH MFG LLC | Merck KGaA (EMD) | pharmaceuticals | air pollution violation | 2007 | EPA | $55,000 |
TEVA PHARMACEUTICALS USA INC | Teva Pharmaceutical Industries | pharmaceuticals | air pollution violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,250,000 |
BOEHRINGER INGELHEIM VETMEDICA, INC | Eli Lilly | pharmaceuticals | air pollution violation | 2011 | EPA | $900,000 |
GLAXOSMITHKLINE VACCINES | GlaxoSmithKline | pharmaceuticals | air pollution violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $172,900 |
Biovail Corporation | Bausch Health | pharmaceuticals | accounting fraud or deficiencies | 2008 | SEC | $10,000,000 |
Elan Corporation, plc | Perrigo | pharmaceuticals | accounting fraud or deficiencies | 2005 | SEC | $15,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | accounting fraud or deficiencies | 2004 | SEC | $150,000,000 |
ICN Pharmaceuticals, Inc. | Bausch Health | pharmaceuticals | accounting fraud or deficiencies | 2002 | SEC | $1,000,000 |
Galena Biopharma, Inc. | SELLAS Life Sciences Group | pharmaceuticals | accounting fraud or deficiencies | 2017 | SEC | $200,000 |
Alere Inc. | Abbott Laboratories | pharmaceuticals | accounting fraud or deficiencies | 2017 | SEC | $13,023,885 |